All Stories

  1. 64 Cu tumor labeling with hexadentate picolinic acid‐based bispidine immunoconjugates
  2. Impact of Viscosity on Human Hepatoma Spheroids in Soft Core–Shell Microcapsules
  3. Preclinical evaluation of an 18F-labeled Nε-acryloyllysine piperazide for covalent targeting of transglutaminase 2
  4. Improving susceptibility of neuroendocrine tumors to radionuclide therapies: personalized approaches towards complementary treatments
  5. Radiosynthesis and biological evaluation of [18F]AG-120 for PET imaging of the mutant isocitrate dehydrogenase 1 in glioma
  6. Lysyl Oxidases as Targets for Cancer Therapy and Diagnostic Imaging
  7. Anti-Cancer Prodrug Cyclophosphamide Exerts Thrombogenic Effects on Human Venous Endothelial Cells Independent of CYP450 Activation—Relevance to Thrombosis
  8. Comparative Saturation Binding Analysis of 64Cu-Labeled Somatostatin Analogues Using Cell Homogenates and Intact Cells
  9. Synthesis and In Vitro Biological Evaluation of p-Carborane-Based Di-tert-butylphenol Analogs
  10. Reactivating damaged motor neurons using magnetic fields
  11. Preclinical Characterization of the 177Lu-Labeled Prostate Stem Cell Antigen (PSCA)-Specific Monoclonal Antibody 7F5
  12. Isonimesulide and Its Carborane Analogues as Isoform‐Selective COX Inhibitors and Antitumor Agents
  13. Carborane‐based Tebufelone Analogs and their Biological Evaluation In Vitro
  14. Specific and safe targeting of glioblastoma using switchable and logic-gated RevCAR T cells
  15. Metastatic pheochromocytoma and paraganglioma: Somatostatin receptor 2 expression, genetics and therapeutic responses
  16. Shell engineering in soft alginate‐based capsules for culturing liver spheroids
  17. Dipeptide-Derived Alkynes as Potent and Selective Irreversible Inhibitors of Cysteine Cathepsins
  18. A self-assembled dynamic extracellular matrix-like hydrogel system with multi-scale structures for cell bioengineering applications
  19. Impedimetric Nanobiosensor for the Detection of SARS-CoV-2 Antigens and Antibodies
  20. Microdialysis Reveals Anti-Inflammatory Effects of Sulfated Glycosaminoglycanes in the Early Phase of Bone Healing
  21. Solid-Phase Parallel Synthesis of Dual Histone Deacetylase-Cyclooxygenase Inhibitors
  22. Prostaglandins and the Lung
  23. The Impact of Nε-Acryloyllysine Piperazides on the Conformational Dynamics of Transglutaminase 2
  24. Modulating the Renal Clearance of Targeted Radiopharmaceuticals
  25. Carborane-based Compounds in Dual Inhibitor Design
  26. Pheochromocytoma radionuclide theranostics and radiation transcriptomics
  27. Carborane Analogues of Fenoprofen Exhibit Improved Antitumor Activity
  28. Impact of Sulfated Hyaluronan on Bone Metabolism in Diabetic Charcot Neuroarthropathy and Degenerative Arthritis
  29. Toward Personalized Medicine: One Chelator for Imaging and Therapy with Lutetium-177 and Actinium-225
  30. Targeting neuropeptide receptors for cancer imaging
  31. New link between dietary phosphate and coronary heart disease
  32. NO• donors in cancer therapy
  33. Case report: Incidentally discovered case of pheochromocytoma as a cause of long COVID-19 syndrome
  34. Better understanding the metabolic stability of radiotracers
  35. Carboranyl Analogues of Mefenamic Acid and Their Biological Evaluation
  36. Application of a Fluorescence Anisotropy-Based Assay to Quantify Transglutaminase 2 Activity in Cell Lysates
  37. The Role of Transglutaminase 2 in the Radioresistance of Melanoma Cells
  38. Acceleration to the next level
  39. Personalized drug testing in human pheochromocytoma/paraganglioma primary cultures
  40. CRISPR/Cas9 Mediated Knockout of Cyclooxygenase-2 Gene Inhibits Invasiveness in A2058 Melanoma Cells
  41. A Self‐Assembled Matrix System for Cell‐Bioengineering Applications in Different Dimensions, Scales, and Geometries
  42. Targeting estrogen receptors in melanoma
  43. Targeting bone with copper radionuclides
  44. “Clickable” Albumin Binders for Modulating the Tumor Uptake of Targeted Radiopharmaceuticals
  45. Solid-Phase Synthesis of Selectively Mono-Fluorobenz(o)ylated Polyamines as a Basis for the Development of 18F-Labeled Radiotracers
  46. Hybrid agents for multimodal imaging
  47. Men who stare at bone: multimodal monitoring of bone healing
  48. Radiolabelled Cyclic Bisarylmercury: High Chemical and in vivo Stability for Theranostics
  49. Modulation of γ-Secretase Activity by a Carborane-Based Flurbiprofen Analogue
  50. Conductive Hydrogels with Dynamic Reversible Networks for Biomedical Applications
  51. Immunocompatibility and non-thrombogenicity of gelatin-based hydrogels
  52. Convergent synthesis of diversified reversible network leads to liquid metal-containing conductive hydrogel adhesives
  53. Development of an 18F-Labeled Irreversible Inhibitor of Transglutaminase 2 as Radiometric Tool for Quantitative Expression Profiling in Cells and Tissues
  54. Development of a ghrelin receptor inverse agonist for positron emission tomography
  55. The transCampus Metabolic Training Programme Explores the Link of SARS-CoV-2 Virus to Metabolic Disease
  56. Response of Endothelial Cells to Gelatin-Based Hydrogels
  57. Pseudohypoxia causes radioresistance
  58. Screening Arrays of Laminin Peptides on Modified Cellulose for Promotion of Adhesion of Primary Endothelial and Neural Precursor Cells
  59. A modular, injectable, non-covalently assembled hydrogel system features widescale tunable degradability for controlled release and tissue integration
  60. The Pyrazolo[3,4-d]pyrimidine-Based Kinase Inhibitor NVP-BHG712: Effects of Regioisomers on Tumor Growth, Perfusion, and Hypoxia in EphB4-Positive A375 Melanoma Xenografts
  61. The influence of different artificial extracellular matrix implant coatings on the regeneration of a critical size femur defect in rats
  62. Pseudohypoxia promotes metastasis
  63. Recent Insights in Barium-131 as a Diagnostic Match for Radium-223: Cyclotron Production, Separation, Radiolabeling, and Imaging
  64. Radiopharmaceutical Cancer Research goes 3D
  65. Metabolomics, machine learning and immunohistochemistry to predict succinate dehydrogenase mutational status in phaeochromocytomas and paragangliomas
  66. Fighting Cancer: Targeting the Eph Receptor Tyrosine Kinase Subfamily
  67. Comparison of manual and automated ventricle segmentation in the maternal immune stimulation rat model of schizophrenia
  68. The sigma-1 receptor: Potential role in the modulation of cellular radiation sensitivity
  69. Adjuvant Drug-Assisted Bone Healing: Advances and Challenges in Drug Delivery Approaches
  70. Carboranyl Derivatives of Rofecoxib with Cytostatic Activity against Human Melanoma and Colon Cancer Cells
  71. Regulation of bone regeneration
  72. Adjuvant drug-assisted bone healing: Part I – Modulation of inflammation
  73. Adjuvant drug-assisted bone healing: Part II – Modulation of angiogenesis
  74. Adjuvant drug-assisted bone healing: Part III – Further strategies for local and systemic modulation
  75. Synthesis, radiolabelling and initial biological characterisation of 18F-labelled xanthine derivatives for PET imaging of Eph receptors
  76. Deuteration versus ethylation – strategies to improve the metabolic fate of an 18F-labeled celecoxib derivative
  77. Fluorescent mouse pheochromocytoma spheroids expressing hypoxia-inducible factor 2 alpha: Morphologic and radiopharmacologic characterization
  78. Active Targeting of Dendritic Polyglycerols for Diagnostic Cancer Imaging
  79. Bone healing made visible
  80. Synthesis and Cyclooxygenase Inhibition of Sulfonamide-Substituted (Dihydro)Pyrrolo[3,2,1-hi]indoles and Their Potential Prodrugs
  81. Pheochromocytoma/Paraganglioma: A Guide for the Practicing Clinician
  82. Characterization of Tissue Transglutaminase as a Potential Biomarker for Tissue Response toward Biomaterials
  83. A theranostic PSMA ligand for PET imaging and retargeting of T cells expressing the universal chimeric antigen receptor UniCAR
  84. Radiochemical and radiopharmacological characterization of a 64 Cu-labeled α-MSH analog conjugated with different chelators
  85. Targeting Cyclooxygenase-2 in Pheochromocytoma and Paraganglioma: Focus on Genetic Background
  86. Cytocompatible, Injectable, and Electroconductive Soft Adhesives with Hybrid Covalent/Noncovalent Dynamic Network
  87. Instant kit preparation of 68Ga-radiopharmaceuticals via the hybrid chelator DATA: clinical translation of [68Ga]Ga-DATA-TOC
  88. Carboranyl Analogues of Ketoprofen with Cytostatic Activity against Human Melanoma and Colon Cancer Cell Lines
  89. Nitric Oxide-Releasing Selective Estrogen Receptor Modulators: A Bifunctional Approach to Improve the Therapeutic Index
  90. Synthesis and preliminary radiopharmacological characterisation of an 11 C-labelled azadipeptide nitrile as potential PET tracer for imaging of cysteine cathepsins
  91. Impact of Extrinsic and Intrinsic Hypoxia on Catecholamine Biosynthesis in Absence or Presence of Hif2α in Pheochromocytoma Cells
  92. Limited importance of EphrinA1–ligand, Src kinase, and focal adhesion kinase in EphA2-mediated regulation of metastasis in Mel-Juso and A375 human melanoma cells
  93. Regulation of A375 melanoma cell adhesion and migration by EphB4 and EphrinB2 – insights from co-culture experiments
  94. Cover Feature: Carboranyl Analogues of Celecoxib with Potent Cytostatic Activity against Human Melanoma and Colon Cancer Cell Lines (ChemMedChem 3/2019)
  95. Carboranyl Analogues of Celecoxib with Potent Cytostatic Activity against Human Melanoma and Colon Cancer Cell Lines
  96. Fluorine-18 Labeling of S100 Proteins for Small Animal Positron Emission Tomography
  97. One-Pot Cascade Synthesis of Pyrazole Based Isosteres of Valdecoxib by a [3+2] Cycloaddition Sequence and Evaluation of Their Cox Inhibitory Activity
  98. Strain-specific metastatic phenotypes in pheochromocytoma allograft mice
  99. Diverse effects of phospholipase A2 receptor expression on LNCaP and PC-3 prostate cancer cell growth in vitro and in vivo
  100. Synthesis, 18F-labelling and radiopharmacological characterisation of the C-terminal 30mer of Clostridium perfringens enterotoxin as a potential claudin-targeting peptide
  101. Development of a novel target module redirecting UniCAR T cells to Sialyl Tn-expressing tumor cells
  102. Exploring pitfalls of 64Cu-labeled EGFR-targeting peptide GE11 as a potential PET tracer
  103. Causative treatment of acid aspiration induced acute lung injury – Recent trends from animal experiments and critical perspective
  104. From mono- to bivalent: improving theranostic properties of target modules for redirection of UniCAR T cells against EGFR-expressing tumor cells in vitro and in vivo
  105. Evaluation of Fluorine-18-Labeled α1(I)-N-Telopeptide Analogs as Substrate-Based Radiotracers for PET Imaging of Melanoma-Associated Lysyl Oxidase
  106. Synthesis, Characterization, and Initial Biological Evaluation of [99m Tc]Tc-Tricarbonyl-labeled DPA-α-MSH Peptide Derivatives for Potential Melanoma Imaging
  107. Nε-Acryloyllysine Piperazides as Irreversible Inhibitors of Transglutaminase 2: Synthesis, Structure–Activity Relationships, and Pharmacokinetic Profiling
  108. Bridging from Brain to Tumor Imaging: (S)-(−)- and (R)-(+)-[18F]Fluspidine for Investigation of Sigma-1 Receptors in Tumor-Bearing Mice
  109. Engrafting human regulatory T cells with a flexible modular chimeric antigen receptor technology
  110. Overexpression of Receptor Tyrosine Kinase EphB4 Triggers Tumor Growth and Hypoxia in A375 Melanoma Xenografts: Insights from Multitracer Small Animal Imaging Experiments
  111. Novel valdecoxib derivatives by ruthenium(ii)-promoted 1,3-dipolar cycloaddition of nitrile oxides with alkynes – synthesis and COX-2 inhibition activity
  112. Retargeting of UniCAR T cells with an in vivo synthesized target module directed against CD19 positive tumor cells
  113. An orthotopic xenograft model for high-risk non-muscle invasive bladder cancer in mice: influence of mouse strain, tumor cell count, dwell time and bladder pretreatment
  114. Development of novel target modules for retargeting of UniCAR T cells to GD2 positive tumor cells
  115. Preparation of a novel radiotracer targeting the EphB4 receptor via radiofluorination using spiro azetidinium salts as precursor
  116. Biological characterization of novel nitroimidazole-peptide conjugates in vitr o and in vivo
  117. Novel Tumor Pretargeting System Based on Complementaryl-Configured Oligonucleotides
  118. In Vivo Examination of an Injectable Hydrogel System Crosslinked by Peptide-Oligosaccharide Interaction in Immunocompetent Nude Mice
  119. Human Endothelial Cell Models in Biomaterial Research
  120. Retargeting of T lymphocytes to PSCA- or PSMA positive prostate cancer cells using the novel modular chimeric antigen receptor platform technology “UniCAR”
  121. Cryogel-supported stem cell factory for customized sustained release of bispecific antibodies for cancer immunotherapy
  122. A novel nanobody-based target module for retargeting of T lymphocytes to EGFR-expressing cancer cells via the modular UniCAR platform
  123. Surface charge and particle size determine the metabolic fate of dendritic polyglycerols
  124. The why and how of amino acid analytics in cancer diagnostics and therapy
  125. Technetium-99m based small molecule radiopharmaceuticals and radiotracers targeting inflammation and infection
  126. Development of a18F-labeled Diaryl-Substituted Dihydropyrrolo[3,2,1-hi]indole as Potential Probe for Functional Imaging of Cyclooxygenase-2 with PET
  127. S100 proteins and scavenger receptors: what's going on?
  128. Zwitterionic Polymer-Coated Ultrasmall Superparamagnetic Iron Oxide Nanoparticles with Low Protein Interaction and High Biocompatibility
  129. Extracellular S100A4 affects endothelial cell integrity and stimulates transmigration of A375 melanoma cells
  130. Corrigendum: Synthesis and Kinetic Characterisation of Water-Soluble Fluorogenic Acyl Donors for Transglutaminase 2
  131. Synthesis and Kinetic Characterisation of Water-Soluble Fluorogenic Acyl Donors for Transglutaminase 2
  132. Development of Antioxidant COX-2 Inhibitors as Radioprotective Agents for Radiation Therapy—A Hypothesis-Driven Review
  133. Interaction of extracellular S100A4 with RAGE prompts prometastatic activation of A375 melanoma cells
  134. 177Lu-labelled macrocyclic bisphosphonates for targeting bone metastasis in cancer treatment
  135. Protective effects of 2,3-diaryl-substituted indole-based cyclooxygenase-2 inhibitors on oxidative modification of human low density lipoproteins in vitro
  136. Controlled immobilization of His-tagged proteins for protein-ligand interaction experiments using Ni2+-NTA layer on glass surfaces
  137. Gelatin-based Hydrogel Degradation and Tissue Interactionin vivo: Insights from Multimodal Preclinical Imaging in Immunocompetent Nude Mice
  138. Multimodal Somatostatin Receptor Theranostics Using [64Cu]Cu-/[177Lu]Lu-DOTA-(Tyr3)octreotate and AN-238 in a Mouse Pheochromocytoma Model
  139. Radiopharmacological characterization of 64Cu-labeled α-MSH analogs for potential use in imaging of malignant melanoma
  140. 68Ga- und 177Lu-markierte Bisphosphonate als Knochenmetastasen-Theranostika
  141. Development of indazolylpyrimidine derivatives as high-affine EphB4 receptor ligands and potential PET radiotracers
  142. Novel (pyrazolyl)benzenesulfonamides with a nitric oxide-releasing moiety as selective cyclooxygenase-2 inhibitors
  143. Copper(II) Cyclam Complexes withN-­Propionic Acid Pendant Arms
  144. Effects of pulmonary acid aspiration on the regional pulmonary blood flow within the first hour after injury: An observational study in rats1
  145. 18F-Labeled 1,4-Dioxa-8-azaspiro[4.5]decane Derivative: Synthesis and Biological Evaluation of a σ1Receptor Radioligand with Low Lipophilicity as Potent Tumor Imaging Agent
  146. Cysteine cathepsins: their role in tumor progression and recent trends in the development of imaging probes
  147. Synthesis and Biodistribution Studies of 3 H- and 64 Cu-Labeled Dendritic Polyglycerol and Dendritic Polyglycerol Sulfate
  148. Diaryl-Substituted (Dihydro)pyrrolo[3,2,1-hi]indoles, a Class of Potent COX-2 Inhibitors with Tricyclic Core Structure
  149. Reduced pulmonary blood flow in regions of injury 2 hours after acid aspiration in rats
  150. Optical imaging of COX-2: Studies on an autofluorescent 2,3-diaryl-substituted indole-based cyclooxygenase-2 inhibitor
  151. Cyclopeptides containing the DEKS motif as conformationally restricted collagen telopeptide analogues: synthesis and conformational analysis
  152. Novel indole-based sigma-2 receptor ligands: synthesis, structure–affinity relationship and antiproliferative activity
  153. Biocompatibility and inflammatory response in vitro and in vivo to gelatin-based biomaterials with tailorable elastic properties
  154. In Vivo Fluorescence Imaging and Urinary Monoamines as Surrogate Biomarkers of Disease Progression in a Mouse Model of Pheochromocytoma
  155. Radiofluorination and first radiopharmacological characterization of a SWLAY peptide-based ligand targeting EphA2
  156. Bispidine Dioxotetraaza Macrocycles: A New Class of Bispidines for 64Cu PET Imaging
  157. Radiolabeled Cetuximab Conjugates for EGFR Targeted Cancer Diagnostics and Therapy
  158. Metastatic potential of B16-F10 melanoma cells is enhanced by extracellular S100A4 derived from RAW264.7 macrophages
  159. ChemInform Abstract: Tissue Transglutaminase: An Emerging Target for Therapy and Imaging
  160. Radiolabeled anti-EGFR-antibody improves local tumor control after external beam radiotherapy and offers theragnostic potential
  161. 2,3-Diaryl-substituted indole based COX-2 inhibitors as leads for imaging tracer development
  162. Organotypical vascular model for characterization of radioprotective compounds: Studies on antioxidant 2,3-diaryl-substituted indole-based cyclooxygenase-2 inhibitors
  163. Synthesis and radiopharmacological evaluation of 64Cu-labeled bombesin analogs featuring a bis(2-pyridylmethyl)-1,4,7-triazacyclononane chelator
  164. Tissue transglutaminase: An emerging target for therapy and imaging
  165. Pulmonary Blood Flow Increases in Damaged Regions Directly after Acid Aspiration in Rats
  166. Optimization of Pentadentate Bispidines as Bifunctional Chelators for64Cu Positron Emission Tomography (PET)
  167. Synthesis and Radiopharmacological Characterisation of a Fluorine-18-Labelled Azadipeptide Nitrile as a Potential PET Tracer for in vivo Imaging of Cysteine Cathepsins
  168. Radiolabeled COX-2 Inhibitors for Non-Invasive Visualization of COX-2 Expression and Activity — A Critical Update
  169. Anti-tumor effects of peptide analogs targeting neuropeptide hormone receptors on mouse pheochromocytoma cells
  170. An Efficient Bioorthogonal Strategy Using CuAAC Click Chemistry for Radiofluorinations of SNEW Peptides and the Role of Copper Depletion
  171. Experimental hypoxia does not influence gene expression and protein synthesis of Eph receptors and ephrin ligands in human melanoma cells in vitro
  172. 2-Carbaborane-3-phenyl-1H-indoles-Synthesis via McMurry Reaction and Cyclooxygenase (COX) Inhibition Activity
  173. Copper(ii) chemistry of the functionalized macrocycle cyclam tetrapropionic acid
  174. Visualization of cyclooxygenase-2 using a 2,3-diarylsubstituted indole-based inhibitor and confocal laser induced cryofluorescence microscopy at 20K in melanoma cells in vitro
  175. 18F-Labeled phosphopeptide-cell-penetrating peptide dimers with enhanced cell uptake properties in human cancer cells
  176. Protein and non-protein biomarkers in melanoma: a critical update
  177. Fluorine-18 Radiolabeling and Radiopharmacological Characterization of a Benzodioxolylpyrimidine-based Radiotracer Targeting the Receptor Tyrosine Kinase EphB4
  178. Radiosynthesis of a 18F-labeled 2,3-diarylsubstituted indole via McMurry coupling for functional characterization of cyclooxygenase-2 (COX-2) in vitro and in vivo
  179. Design, Evaluation, and Comparison of Ghrelin Receptor Agonists and Inverse Agonists as Suitable Radiotracers for PET Imaging
  180. Irradiation affects cellular properties and Eph receptor expression in human melanoma cells
  181. Site-selective radiolabeling of peptides by 18F-fluorobenzoylation with [18F]SFB in solution and on solid phase: a comparative study
  182. Cyclin-Dependent Kinases (Cdk) as Targets for Cancer Therapy and Imaging
  183. Specific Targeting of Hypoxic Tumor Tissue with Nitroimidazole-Peptide Conjugates
  184. Synthesis of an 18F-labeled cyclin-dependent kinase-2 inhibitor
  185. Automated radiosynthesis of the thiol-reactive labeling agent N-[6-(4-[18F]fluorobenzylidene)aminooxyhexyl]maleimide ([18F]FBAM)
  186. Copper-mediated cross-linking of S100A4, but not of S100A2, results in proinflammatory effects in melanoma cells
  187. Phosphopeptides with improved cellular uptake properties as ligands for the polo-box domain of polo-like kinase 1
  188. A novel tetrabranched neurotensin(8–13) cyclam derivative: Synthesis, 64Cu-labeling and biological evaluation
  189. Synthesis, characterization and biological evaluation of [188Re(N)(cys∼)(PNP)]+/0 mixed-ligand complexes as prototypes for the development of 188Re(N)-based target-specific radiopharmaceuticals
  190. Synthesis and evaluation of 1,5-diaryl-substituted tetrazoles as novel selective cyclooxygenase-2 (COX-2) inhibitors
  191. Expression, purification and fluorine-18 radiolabeling of recombinant S100A4: a potential probe for molecular imaging of receptor for advanced glycation endproducts in vivo?
  192. S100 proteins in health and disease
  193. Modulation of Adrenal Aldosterone Release by Oxidative Modification of Low-Density Lipoprotein
  194. S100A2 in cancerogenesis: a friend or a foe?
  195. Cyclin-Dependent Kinase 4/6 (Cdk4/6) Inhibitors: Perspectives in Cancer Therapy and Imaging
  196. Synthesis of neurotensin(8–13)–phosphopeptide heterodimers via click chemistry
  197. Scavenger receptors are associated with cellular interactions of S100A12 in vitro and in vivo
  198. Improved multimodality imaging using alginate molding in xenograft tumor models
  199. Effects of posture on regional pulmonary blood flow in rats as measured by PET
  200. Radiosynthesis and radiopharmacological evaluation of cyclin-dependent kinase 4 (Cdk4) inhibitors
  201. Eph receptors and ephrins: bloody players
  202. Influence of irradiation on metabolism and metastatic potential of B16-F10 melanoma cells
  203. Validation of 99mTc-labeled “4+1” fatty acids for myocardial metabolism and flow imaging
  204. Validation of 99mTc-labeled “4+1” fatty acids for myocardial metabolism and flow imaging
  205. Radiosynthesis and radiopharmacological evaluation of [N-methyl-11C]Org 34850 as a glucocorticoid receptor (GR)-binding radiotracer
  206. Synthesis and cyclooxygenase inhibition of various (aryl-1,2,3-triazole-1-yl)-methanesulfonylphenyl derivatives
  207. Cell Cycle Regulating Kinase Cdk4 as a Potential Target for Tumor Cell Treatment and Tumor Imaging
  208. Erratum
  209. Fluorine-18 labeling of phosphopeptides: A potential approach for the evaluation of phosphopeptide metabolism in vivo
  210. Reduction of Arteriosclerotic Nanoplaque Formation and Size by n-3 Fatty Acids in Patients after Valvular Defect Operation
  211. Effects of pioglitazone and/or simvastatin on low density lipoprotein subfractions in non-diabetic patients with high cardiovascular risk: A sub-analysis from the PIOSTAT study
  212. Prediabetic and diabetic in vivo modification of circulating low-density lipoprotein attenuates its stimulatory effect on adrenal aldosterone and cortisol secretion
  213. Synthesis and evaluation in vitro and in vivo of a 11C-labeled cyclooxygenase-2 (COX-2) inhibitor
  214. Radiolabeled Glucocorticoids as Molecular Probes for Imaging Brain Glucocorticoid Receptors by Means of Positron Emission Tomography (PET)
  215. Synthesis and Application of [18F]FDG-Maleimidehexyloxime ([18F]FDG-MHO): A [18F]FDG-Based Prosthetic Group for the Chemoselective18F-Labeling of Peptides and Proteins†
  216. Human S100A12: a novel key player in inflammation?
  217. Systematic comparison of two novel, thiol-reactive prosthetic groups for 18F labeling of peptides and proteins with the acylation agent succinimidyl-4-[18F]fluorobenzoate ([18F]SFB)
  218. Expression, purification and fluorine-18 radiolabeling of recombinant S100 proteins—potential probes for molecular imaging of receptor for advanced glycation endproducts (RAGE) in vivo
  219. Glycoxidation of Low Density Lipoprotein in Impaired Glucose Tolerance: Implications for the Pathogenesis of Diabetic Vascular Disease
  220. Yttrium-86-labelled human serum albumin microspheres: relation of surface structure with in vivo stability
  221. Modified “4 + 1” Mixed Ligand Technetium-Labeled Fatty Acids for Myocardial Imaging: Evaluation of Myocardial Uptake and Biodistribution
  222. L-Type Amino Acid Transporters LAT1 and LAT4 in Cancer: Uptake of 3-O-Methyl-6- 18F-Fluoro-L-Dopa in Human Adenocarcinoma and Squamous Cell Carcinoma In Vitro and In Vivo
  223. Localized proton magnetic resonance spectroscopy of lipids in adipose tissue at high spatial resolution in mice in vivo
  224. Factors influencing the formation of small dense low-density lipoprotein particles in dependence on the presence of the metabolic syndrome and on the degree of glucose intolerance
  225. Experimental hypoxia is a potent stimulus for radiotracer uptake in vitro: Comparison of different tumor cells and primary endothelial cells
  226. Myocardial uptake and biodistribution of newly designed technetium-labelled fatty acid analogues
  227. Synthesis and radiopharmacological characterization of [11C]AL-438 as a nonsteroidal ligand for imaging brain glucocorticoid receptors
  228. Glycoxidised LDL isolated from subjects with impaired glucose tolerance increases CD36 and peroxisome proliferator–activator receptor γ gene expression in macrophages
  229. Labeling of low-density lipoproteins using the 18F-labeled thiol-reactive reagent N-[6-(4-[18F]fluorobenzylidene)aminooxyhexyl]maleimide
  230. Lipid transfer protein activities in subjects with impaired glucose tolerance
  231. Synthesis and Biological Evaluation of a New Type of99mTechnetium-Labeled Fatty Acid for Myocardial Metabolism Imaging
  232. Biodistribution and catabolism of 18F-labeled N-ε-fructoselysine as a model of Amadori products
  233. Positron emission tomography in food sciences
  234. Glucose-Induced Enhancement of Hemin-Catalyzed LDL Oxidation In Vitro and In Vivo
  235. Small animal positron emission tomography in food sciences
  236. Catabolism of native and oxidized low density lipoproteins: in vivo insights from small animal positron emission tomography studies
  237. Synthesis and biodistribution of an 18F-labelled resveratrol derivative for small animal positron emission tomography
  238. Biodistribution and catabolism of 18F-labelled isopeptide Nɛ-(γ-glutamyl)-L-lysine
  239. Fluorine-18 radiolabeling of low-density lipoproteins: a potential approach for characterization and differentiation of metabolism of native and oxidized low-density lipoproteins in vivo
  240. Oxidativ modifizierte Lipoproteine und deren Antik�rper bei Patienten mit Antiphospholipidsyndrom und Systemischem Lupus erythematodes
  241. The pivotal role of scavenger receptor CD36 and phagocyte-derived oxidants in oxidized low density lipoprotein-induced adhesion to endothelial cells
  242. The protective effects of HDL and its constitutents against neutrophil respiratory burst activation by hypochlorite-oxidized LDL
  243. The effect of garlic on arteriosclerotic nanoplaque formation and size
  244. Analysis of non-protein amino acids as specific markers of low density lipoprotein apolipoprotein B-100 oxidation in human atherosclerotic lesions: the use ofN(O)-ethoxycarbonyl trifluoroethyl ester derivatives and GC-MS1
  245. Analysis of 6-hydroxy-2-aminocaproic acid (HACA) as a specific marker of protein oxidation: The use of N(O,S)-ethoxycarbonyl trifluoroethyl ester derivatives and gas chromatography/mass spectrometry
  246. Measurement of 5-hydroxy-2-aminovaleric acid as a specific marker of metal catalysed oxidation of proline and arginine residues of low density lipoprotein apolipoprotein B-100 in human atherosclerotic lesions
  247. Lack of Association between Serum Paraoxonase 1 Activities and Increased Oxidized Low-Density Lipoprotein Levels in Impaired Glucose Tolerance and Newly Diagnosed Diabetes Mellitus
  248. Analysis of 3-chlorotyrosine as a specific marker of protein oxidation: the use ofN(O,S)-ethoxycarbonyltrifluoroethyl ester derivatives and gas chromatography/mass spectrometry
  249. Validation of different chemilumigenic substrates for detecting extracellular generation of reactive oxygen species by phagocytes and endothelial cells
  250. In Vivo Evidence for Increased Oxidation of Circulating LDL in Impaired Glucose Tolerance
  251. Protective Effects of Native But Not Oxidized High-Density Lipoprotein against Proinflammatory Respiratory Burst Activities of Polymorphonuclear Leukocytes Induced by Hypochlorite-Oxidized Low-Density Lipoprotein
  252. UVB-Induced Conversion of 7-Dehydrocholesterol to 1α,25-Dihydroxyvitamin D3 in an In Vitro Human Skin Equivalent Model
  253. Homocysteine levels in patients treated with lipid apheresis: effect of a vitamin therapy
  254. Different susceptibility to oxidation of proline and arginine residues of apolipoprotein B-100 among subspecies of low density lipoproteins
  255. Oxidation of Apolipoprotein B-100 in Circulating LDL Is Related to LDL Residence Time
  256. Impaired glucose tolerance (IGT) is not associated with disturbed homocysteine metabolism
  257. Conversion of vitamin D3 to 1alpha,25-dihydroxyvitamin D3 in human skin equivalents
  258. Measurement of 5-Hydroxy-2-aminovaleric Acid as a Specific Marker of Iron-Mediated Oxidation of Proline and Arginine Side-Chain Residues of Low-Density Lipoprotein Apolipoprotein B-100
  259. Urate modifies lipoprotein oxidation
  260. Human secretory group IIA phospholipase A2 is associated with lipid metabolism
  261. Störungen des Lipid- und Lipoproteinstoffwechsels
  262. Metabolic Basis of Low High Density Lipoprotein in Subjects with Impaired Glucose Tolerance
  263. Very Low Density Lipoprotein Overproduction Is Maximally Expressed in Early Insulin Resistant States
  264. In vivo evidence for increased apolipoprotein A-I catabolism in subjects with impaired glucose tolerance
  265. Human keratinocyte line HaCaT metabolizes 1α-hydroxyvitamin D3 and vitamin D3 to 1α,25-dihydroxyvitamin D3 (calcitriol)
  266. Determination of Total Homocysteine
  267. Hypochlorite-modified low-density lipoprotein stimulates human polymorphonuclear leukocytes for enhanced production of reactive oxygen metabolites, enzyme secretion, and adhesion to endothelial cells
  268. Stable isotope ratio analysis of amino acids: the use ofN(O,S)-ethoxycarbonyl trifluoroethyl ester derivatives and gas chromatography/mass spectrometry
  269. Rapid Determination of Total Homocysteine in Human Plasma by Using N(O,S)-Ethoxycarbonyl Ethyl Ester Derivatives and Gas Chromatography–Mass Spectrometry,
  270. Very fast ultracentrifugation of serum lipoproteins: influence on lipoprotein separation and composition
  271. Recovery of Cholesterol and Triacylglycerol in Very-Fast Ultracentrifugation of Human Lipoproteins in a Large Range of Concentrations
  272. Very-fast ultracentrifugation of human plasma lipoproteins: influence of the centrifugal field on lipoprotein composition